Pelosi Statement on Additional Aid to States In Medicare Part D Payments

Saturday, February 20, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

WASHINGTON, Feb. 19 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi released the following

statement in response to Health and Human Services Secretary Kathleen Sebelius' decision to increase aid to states by $4.3 billion in reimbursements for Medicare Part D prescription drug coverage
for dual eligibles due to the federal medical assistance percentage payments (FMAP) increase under the American Recovery and Reinvestment Act:

"I applaud the Administration's decision, which will mean much-needed relief to states facing severe budget constraints in light of the tough economic climate. The California Congressional delegation's diligence in raising this issue with HHS has paid dividends for California, which will be rewarded with an additional $680 million, all due to the FMAP increase included in the Recovery Act that we passed a year ago.

"As I noted to Governor Schwarzenegger when we met in Washington recently, the Recovery Act will deliver more than $83 billion to California and has already generated more than 250,000 jobs in our state and continues to fulfill its mission of generating jobs and economic growth. The House has also passed the Jobs for Main Street Act, providing billions more in relief for states, including a six-month extension of the enhanced FMAP, which would continue this additional aid to states."

Background:

The American Recovery and Reinvestment Act included a temporary increase for states in federal medical assistance percentage payments (FMAP). This decision applies the enhanced FMAP rates on "clawback" payments made by states to the federal government to offset the costs of added expense to Medicare Part D for assuming the cost of prescription drugs for individuals who are eligible for both Medicare and Medicaid.

SOURCE Office of the Speaker of the House



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook